Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Atkin

Showing results (31-40 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|May 24, 2000
Response of estrogen receptor containing tumour cells to pure antiestrogens and the calmodulin inhibitor, calmidzolium chlorideC J Newton, K Eycott, V Green, et al.
In Vitro Cellular & Developmental Biology. Animal|October 1, 1995
Hypotonic lysis of red blood cell contamination from human anterior pituitary adenoma cell preparationsS L Atkin, L Hipkin, J Radcliffe, et al.
The Journal of Laryngology and Otology|March 24, 2010
Management of carcinoma showing thymus-like elementD Biswas, L Karsai, S L Atkin, et al.
The Journal of Endocrinology|April 20, 2001
Dexamethasone blocks antioestrogen- and oxidant-induced death of pituitary tumour cellsC J Newton, D Bilko, S Pappa, et al.
Diabetes, Obesity & Metabolism|January 30, 2013
The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover studyT Sathyapalan, J Shepherd, S L Atkin, et al.
Scientific Reports|November 20, 2015
Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosisT Sathyapalan, R David, N J Gooderham, et al.
Annals of Clinical Biochemistry|April 25, 2009
The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetesLi Wei Cho, V Jayagopal, E S Kilpatrick, et al.
The Journal of Laryngology and Otology|September 30, 2004
Somatostatin analogues have no role in the treatment of advanced differentiated thyroid cancerO Alhamarneh, J Murphy, S L Atkin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2013
Biological variation of cardiovascular risk factors in patients with diabetesA J Dawson, T Sathyapalan, S L Atkin, et al.
British Journal of Cancer|November 26, 1999
In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6V Speirs, D S Walton, M C Hall, et al.
Pageof 13

Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Steroid Biochemistry and Molecular Biology|May 24, 2000
Response of estrogen receptor containing tumour cells to pure antiestrogens and the calmodulin inhibitor, calmidzolium chlorideC J Newton, K Eycott, V Green, et al.
In Vitro Cellular & Developmental Biology. Animal|October 1, 1995
Hypotonic lysis of red blood cell contamination from human anterior pituitary adenoma cell preparationsS L Atkin, L Hipkin, J Radcliffe, et al.
The Journal of Laryngology and Otology|March 24, 2010
Management of carcinoma showing thymus-like elementD Biswas, L Karsai, S L Atkin, et al.
The Journal of Endocrinology|April 20, 2001
Dexamethasone blocks antioestrogen- and oxidant-induced death of pituitary tumour cellsC J Newton, D Bilko, S Pappa, et al.
Diabetes, Obesity & Metabolism|January 30, 2013
The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover studyT Sathyapalan, J Shepherd, S L Atkin, et al.
Scientific Reports|November 20, 2015
Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosisT Sathyapalan, R David, N J Gooderham, et al.
Annals of Clinical Biochemistry|April 25, 2009
The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetesLi Wei Cho, V Jayagopal, E S Kilpatrick, et al.
The Journal of Laryngology and Otology|September 30, 2004
Somatostatin analogues have no role in the treatment of advanced differentiated thyroid cancerO Alhamarneh, J Murphy, S L Atkin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2013
Biological variation of cardiovascular risk factors in patients with diabetesA J Dawson, T Sathyapalan, S L Atkin, et al.
British Journal of Cancer|November 26, 1999
In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6V Speirs, D S Walton, M C Hall, et al.
Pageof 13